The Swiss market closed on a high note on Wednesday, buoyed by optimism about a rate cut by the Swiss central bank next month. The benchmark SMI gained 0.42% to close at 12,348.70. In this favorable economic climate, identifying high-growth technology stocks like Basilea Pharmaceutica is crucial for investors looking to benefit from continued buying trends and solid market performance.

The 10 fastest growing technology companies in Switzerland

Click here to see the full list of 10 stocks from our SIX Swiss Exchange High Growth Tech and AI Stocks screener.

We examine a selection of our screener results.

Simply Wall St Growth Rating: ★★★★★☆

Overview: Basilea Pharmaceutica Ltd. is a commercial-stage biopharmaceutical company specializing in oncology and anti-infective therapies with a market capitalization of CHF 556.36 million.

Operations: Basilea Pharmaceutica Ltd. focuses on the development and commercialization of innovative pharmaceutical products and generates sales of CHF 149.02 million. The company is primarily active in the therapeutic areas of oncology and anti-infectives.

Basilea Pharmaceutica’s sales are expected to grow by 10.1% annually, outperforming the Swiss market at 4.4%. The company is investing significantly in research and development, with expenses reaching CHF 36 million in the first half of 2024, reflecting the company’s commitment to innovation. The recent approval of Cresemba® for pediatric use by the European Commission extends market exclusivity by two years and triggered a CHF 10 million milestone at Pfizer. Despite current unprofitability, Basilea is expected to be profitable within three years, with an impressive future return on equity forecast at 83.8%.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: LEM Holding SA, together with its subsidiaries, offers solutions for measuring electrical parameters in regions such as China, Japan, South Korea, India, Southeast Asia, Europe, the Middle East, Africa, NAFTA and Latin America and has a market capitalization of CHF 1.39 billion.

The story continues

Operations: LEM Holding SA specializes in providing solutions for measuring electrical parameters in different regions of the world. The company generates its revenue mainly through the sale of these measurement solutions, with the markets of China, Japan, South Korea, India and Europe making a significant contribution.

LEM Holding’s revenue is expected to grow by 9.2% annually, outperforming the Swiss market at 4.4%. Despite recent earnings difficulties, which saw net profit fall year-on-year from CHF 20.54 million to CHF 4.78 million, LEM’s focus on innovation remains strong, as evidenced by significant R&D investments of CHF 36 million in the first half of 2024. The company’s profit is expected to grow by an impressive 18.37% annually over the next few years, indicating solid future prospects in the technology sector.

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Temenos AG develops, markets and sells integrated banking software systems to financial institutions worldwide and has a market capitalization of CHF 4.21 billion.

Operations: Temenos generates revenue by providing integrated banking software systems to financial institutions worldwide. The company’s business model includes licensing fees, maintenance fees and service fees for its software products.

Temenos is poised for growth and expects revenue to grow by 7.6% annually, outperforming the Swiss market at 4.4%. The company’s profit is expected to grow by a solid 14.3% per year, driven by strategic investments in research and development, which amounted to CHF 36 million in recent quarters. Recent executive appointments are aimed at strengthening the company’s presence in the SaaS space and in the US market. At the same time, the company has repurchased CHF 110 million worth of shares, increasing value for shareholders.

Take advantage of the opportunity

• Get an insight into the universe of 10 high growth tech and AI stocks on the SIX Swiss Exchange by clicking here.

• Are you interested in these stocks? Improve your management by using the Simply Wall St. portfolio, which offers intuitive tools to help you optimize your investment results.

• Optimize your investment strategy for free with the Simply Wall St app and benefit from comprehensive research on stocks from all over the world.

Ready for a different approach?

This Simply Wall St article is of a general nature. We comment solely on the basis of historical data and analyst forecasts, using an unbiased methodology. Our articles do not constitute financial advice. It is not a recommendation to buy or sell any stock and does not take into account your objectives or financial situation. Our goal is to provide you with long-term analysis based on fundamental data. Note that our analysis may not take into account the latest price-sensitive company announcements or qualitative materials. Simply Wall St does not hold any of the stocks mentioned.

Companies discussed in this article include SWX:BSLN, SWX:LEHN and SWX:TEMN.

Do you have feedback on this article? Are you interested in the content? Contact us directly. Alternatively, send an email to [email protected]